Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa

Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa This article was published in the SA Journal of Oncology, 01 October 2020 https://doi.org/10.4102/sajo.v4i0.138 Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are rare neoplasms arising fromthe endocrine cells of the gastrointestinal (GI) tract and the pancreas that secreteContinue reading “Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa”